Zobrazeno 1 - 10 of 31 pro vyhledávání: '"Rantala JK"'
5
Akademický článek
In-vitro assays for immuno-oncology drug efficacy assessment and screening for personalized cancer therapy: scopes and challenges.
Autor: Rahman MM; Sheffield Ex vivo Group, Division of Clinical Medicine, School of Medicine & Population Health, University of Sheffield, Sheffield, UK.; Directorate General of Health Services, Dhaka, Bangladesh., Wells G; Sheffield Ex vivo Group, Division of Clinical Medicine, School of Medicine & Population Health, University of Sheffield, Sheffield, UK., Rantala JK; Sheffield Ex vivo Group, Division of Clinical Medicine, School of Medicine & Population Health, University of Sheffield, Sheffield, UK.; Misvik Biology Ltd, Turku, Finland., Helleday T; Sheffield Ex vivo Group, Division of Clinical Medicine, School of Medicine & Population Health, University of Sheffield, Sheffield, UK.; Department of Oncology-Pathology, Karolinska Institutet, Huddinge, Sweden., Muthana M; Nanobug Oncology Sheffield, Division of Clinical Medicine, School of Medicine & Population Health, University of Sheffield, Sheffield, UK., Danson SJ; Sheffield Ex vivo Group, Division of Clinical Medicine, School of Medicine & Population Health, University of Sheffield, Sheffield, UK.
Publikováno v: Expert review of clinical immunology [Expert Rev Clin Immunol] 2024 Aug; Vol. 20 (8), pp. 821-838. Date of Electronic Publication: 2024 Apr 03.
Zobrazit plný text záznamu
6
Akademický článek
Assessment of targeted therapy opportunities in sinonasal cancers using patient-derived functional tumor models.
Autor: Lehtinen N; Misvik Biology Oy, Turku, Finland., Suhonen J; Misvik Biology Oy, Turku, Finland., Rice K; Misvik Biology Oy, Turku, Finland., Välimäki E; Misvik Biology Oy, Turku, Finland., Toriseva M; Turku Bioscience Centre, University of Turku and Åbo Akademi University, Turku, Finland; FICAN West Cancer Centre, Turku, Finland., Routila J; Turku Bioscience Centre, University of Turku and Åbo Akademi University, Turku, Finland; Department for Otorhinolaryngology - Head and Neck Surgery, University of Turku and Turku University Hospital, Turku, Finland., Halme P; Turku Bioscience Centre, University of Turku and Åbo Akademi University, Turku, Finland; Department for Otorhinolaryngology - Head and Neck Surgery, University of Turku and Turku University Hospital, Turku, Finland., Rahi M; Department of Neurosurgery, Neurocenter, Turku University Hospital, Turku, Finland; Clinical Neurosciences, University of Turku, Turku, Finland., Irjala H; Turku Bioscience Centre, University of Turku and Åbo Akademi University, Turku, Finland; Department for Otorhinolaryngology - Head and Neck Surgery, University of Turku and Turku University Hospital, Turku, Finland., Leivo I; Turku Bioscience Centre, University of Turku and Åbo Akademi University, Turku, Finland; Department of Pathology, University of Turku and Turku University Hospital, Turku, Finland., Kallajoki M; Department of Pathology, University of Turku and Turku University Hospital, Turku, Finland., Nees M; Turku Bioscience Centre, University of Turku and Åbo Akademi University, Turku, Finland; FICAN West Cancer Centre, Turku, Finland; Department of Biochemistry and Molecular Biology, Medical University of Lublin, Lublin, Poland., Kuopio T; Department of Biological and Environmental Science, University of Jyväskylä, Jyväskylä, Finland; Wellbeing Services County of Central Finland, Jyväskylä, Finland., Ventelä S; Turku Bioscience Centre, University of Turku and Åbo Akademi University, Turku, Finland; FICAN West Cancer Centre, Turku, Finland; Department for Otorhinolaryngology - Head and Neck Surgery, University of Turku and Turku University Hospital, Turku, Finland., Rantala JK; Misvik Biology Oy, Turku, Finland. Electronic address: rantala@misvik.com.
Publikováno v: Translational oncology [Transl Oncol] 2024 Jun; Vol. 44, pp. 101935. Date of Electronic Publication: 2024 Mar 23.
Zobrazit plný text záznamu
7
Akademický článek
Defined extracellular matrix compositions support stiffness-insensitive cell spreading and adhesion signaling.
Autor: Conway JRW; Turku Bioscience Centre, University of Turku and Åbo Akademi University, Turku FI-20520, Finland., Isomursu A; Turku Bioscience Centre, University of Turku and Åbo Akademi University, Turku FI-20520, Finland., Follain G; Turku Bioscience Centre, University of Turku and Åbo Akademi University, Turku FI-20520, Finland., Härmä V; Misvik Biology Oy, Turku FI-20520, Finland.; Department of Oncology and Metabolism, University of Sheffield, Sheffield S10 2TN, United Kingdom., Jou-Ollé E; Turku Bioscience Centre, University of Turku and Åbo Akademi University, Turku FI-20520, Finland., Pasquier N; Turku Bioscience Centre, University of Turku and Åbo Akademi University, Turku FI-20520, Finland., Välimäki EPO; Misvik Biology Oy, Turku FI-20520, Finland., Rantala JK; Misvik Biology Oy, Turku FI-20520, Finland.; Department of Oncology and Metabolism, University of Sheffield, Sheffield S10 2TN, United Kingdom., Ivaska J; Turku Bioscience Centre, University of Turku and Åbo Akademi University, Turku FI-20520, Finland.; Department of Life Technologies, University of Turku, Turku FI-20520, Finland.; InFLAMES Research Flagship, University of Turku, Turku FI-20520, Finland.; Western Finnish Cancer Center, University of Turku, Turku FI-20520, Finland.; Foundation for the Finnish Cancer Institute, Helsinki FI-00014, Finland.
Publikováno v: Proceedings of the National Academy of Sciences of the United States of America [Proc Natl Acad Sci U S A] 2023 Oct 24; Vol. 120 (43), pp. e2304288120. Date of Electronic Publication: 2023 Oct 16.
Zobrazit plný text záznamu
8
Akademický článek
FBXL12 degrades FANCD2 to regulate replication recovery and promote cancer cell survival under conditions of replication stress.
Autor: Brunner A; Department of Cell and Molecular Biology, Karolinska Institutet, Solna 17165, Stockholms län, Sweden. Electronic address: andra.brunner@ki.se., Li Q; Department of Cell and Molecular Biology, Karolinska Institutet, Solna 17165, Stockholms län, Sweden., Fisicaro S; Department of Cell and Molecular Biology, Karolinska Institutet, Solna 17165, Stockholms län, Sweden., Kourtesakis A; Department of Cell and Molecular Biology, Karolinska Institutet, Solna 17165, Stockholms län, Sweden., Viiliäinen J; Department of Cell and Molecular Biology, Karolinska Institutet, Solna 17165, Stockholms län, Sweden., Johansson HJ; Department of Oncology and Pathology, Karolinska Institutet, Science for Life Laboratory, Solna 17165, Stockholms län, Sweden., Pandey V; Department of Biological Chemistry, University of California, Los Angeles, Los Angeles 90095, CA, USA., Mayank AK; Department of Biological Chemistry, University of California, Los Angeles, Los Angeles 90095, CA, USA., Lehtiö J; Department of Oncology and Pathology, Karolinska Institutet, Science for Life Laboratory, Solna 17165, Stockholms län, Sweden., Wohlschlegel JA; Department of Biological Chemistry, University of California, Los Angeles, Los Angeles 90095, CA, USA., Spruck C; NCI-Designated Cancer Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla 92037, CA, USA., Rantala JK; Department of Oncology and Metabolism, University of Sheffield, Sheffield S10 2RX, South Yorkshire, UK; Misvik Biology, Turku 20520, Finland., Orre LM; Department of Oncology and Pathology, Karolinska Institutet, Science for Life Laboratory, Solna 17165, Stockholms län, Sweden., Sangfelt O; Department of Cell and Molecular Biology, Karolinska Institutet, Solna 17165, Stockholms län, Sweden. Electronic address: olle.sangfelt@ki.se.
Publikováno v: Molecular cell [Mol Cell] 2023 Oct 19; Vol. 83 (20), pp. 3720-3739.e8. Date of Electronic Publication: 2023 Aug 16.
Zobrazit plný text záznamu
9
Akademický článek
Cisplatin overcomes radiotherapy resistance in OCT4-expressing head and neck squamous cell carcinoma.
Autor: Routila J; Turku Bioscience Centre, University of Turku and Åbo Akademi University, Turku, Finland; Department for Otorhinolaryngology - Head and Neck Surgery, University of Turku and Turku University Hospital, Kiinamyllynkatu 4-8, 20521 Turku, Finland., Qiao X; Turku Bioscience Centre, University of Turku and Åbo Akademi University, Turku, Finland., Weltner J; Department of Clinical Science, Intervention and Technology, Karolinska Institutet, SE-14186 Stockholm, Sweden and Division of Obstetrics and Gynecology, Karolinska Universitetssjukhuset, SE-14186 Stockholm, Sweden., Rantala JK; MISVIK Biology Ltd, Karjakatu 35 B, 20520 Turku, Finland., Carpén T; Department for Otorhinolaryngology - Head and Neck Surgery, Helsinki University Hospital and University of Helsinki, P.O.Box 263, FI-00029 HUS Helsinki, Finland., Hagström J; Department of Oral Pathology and Radiology, University of Turku, Turku, Finland., Mäkitie A; Department for Otorhinolaryngology - Head and Neck Surgery, Helsinki University Hospital and University of Helsinki, P.O.Box 263, FI-00029 HUS Helsinki, Finland., Leivo I; Department of Oral Pathology and Radiology, University of Turku, Turku, Finland; Institute of Biomedicine, Pathology, University of Turku, Kiinamyllynkatu 10 D, 20520 Turku, Finland., Ruuskanen M; Department for Otorhinolaryngology - Head and Neck Surgery, University of Turku and Turku University Hospital, Kiinamyllynkatu 4-8, 20521 Turku, Finland., Söderlund J; Department of Obstetrics and Gynecology, Turku University Hospital and University of Turku, Turku, Finland., Rintala M; Department of Obstetrics and Gynecology, Turku University Hospital and University of Turku, Turku, Finland., Hietanen S; Department of Obstetrics and Gynecology, Turku University Hospital and University of Turku, Turku, Finland; FICAN West Cancer Centre, Turku, Finland., Irjala H; Department for Otorhinolaryngology - Head and Neck Surgery, University of Turku and Turku University Hospital, Kiinamyllynkatu 4-8, 20521 Turku, Finland., Minn H; FICAN West Cancer Centre, Turku, Finland; Department of Oncology and Radiotherapy, University of Turku and Turku University Hospital, Turku, Finland., Westermarck J; Turku Bioscience Centre, University of Turku and Åbo Akademi University, Turku, Finland; Biomedical Institute, University of Turku, Kiinamyllynkatu 10, 20520 Turku, Finland; FICAN West Cancer Centre, Turku, Finland., Ventelä S; Turku Bioscience Centre, University of Turku and Åbo Akademi University, Turku, Finland; Department for Otorhinolaryngology - Head and Neck Surgery, University of Turku and Turku University Hospital, Kiinamyllynkatu 4-8, 20521 Turku, Finland; FICAN West Cancer Centre, Turku, Finland. Electronic address: satuve@utu.fi.
Publikováno v: Oral oncology [Oral Oncol] 2022 Apr; Vol. 127, pp. 105772. Date of Electronic Publication: 2022 Mar 01.
Zobrazit plný text záznamu
10
Akademický článek
Ex Vivo Drug Screening Informed Targeted Therapy for Metastatic Parotid Squamous Cell Carcinoma.
Autor: Nykänen N; Misvik Biology Oy, Turku, Finland., Mäkelä R; Misvik Biology Oy, Turku, Finland., Arjonen A; Misvik Biology Oy, Turku, Finland., Härmä V; Misvik Biology Oy, Turku, Finland.; Department of Oncology and Metabolism, University of Sheffield, Sheffield, United Kingdom., Lewandowski L; Misvik Biology Oy, Turku, Finland., Snowden E; Genomic Sciences, BD Technologies, Research Triangle Park, Durham, NC, United States., Blaesius R; Genomic Sciences, BD Technologies, Research Triangle Park, Durham, NC, United States., Jantunen I; Central Finland Health Care District, Jyväskylä, Finland., Kuopio T; Central Finland Health Care District, Jyväskylä, Finland.; Department of Biological and Environmental Science, Jyväskylä, Finland., Kononen J; Docrates Cancer Center, Helsinki, Finland., Rantala JK; Misvik Biology Oy, Turku, Finland.; Department of Oncology and Metabolism, University of Sheffield, Sheffield, United Kingdom.
Publikováno v: Frontiers in oncology [Front Oncol] 2021 Sep 16; Vol. 11, pp. 735820. Date of Electronic Publication: 2021 Sep 16 (Print Publication: 2021).
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje